TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Detection rate of adenomatous polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clock test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PSM (Progressive Sperm Motility)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DFI (DNA Fragmentation Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Density of intratumoral and stromal CD4+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Global improvement in MSK condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in clinical indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrinsic motivation scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Highest hourly NO2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Air quality outcomes
Primary endpoint: Mean NO2 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Air quality outcomes
Primary endpoint: 48-hour personal exposure to NO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Air quality outcomes
Primary endpoint: Reading comprehension skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Listening comprehension skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tooth Sensitivity (TS) intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleaching Efficacy (BE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac events (CE)
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in spatiotemporal gait parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ankle and foot angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F0 change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jitter change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shimmer change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NHR change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary outcome occurrence
Endpoint domain: Mortality/survival
Primary endpoint: Gross motor development scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertigo scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative relapse-free rate
Endpoint domain: Mortality/survival
Primary endpoint: severity of insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: In-to-out (I/O) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attentional bias to weight-related images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of POAG cases discerned from controls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful haemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Revision surgery for re-bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Generalized Anxiety Disorder Scale Score (GDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suitability for EGFR testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of abnormal cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of suspected vaginitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving MH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean hsCRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean faecal calprotectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain scores the evening of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with positive depression screening results
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of emergency medical visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean seizure/month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: cognitive performances
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: quality of social relations
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: recovery to RRT independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: muscle architecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in intraoperative C acnes load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: postprandial bile acid response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: gut hormone responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: EDB CMAP amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose levels after 120 min in a 75 g OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Matuda index (insulin resistance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: wound closure percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: rate of retinal reattachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Post-ERCP pancreatitis (PEP)
Endpoint domain: Adverse events/effects
Primary endpoint: AES scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CL scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neurobehavioral functioning
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: PRU (Platelet Reactivity Unit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HOPR (High On-treatment Platelet Reactivity)
Endpoint domain: Adverse events/effects
Primary endpoint: time to cardiovascular death or first HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in behavioral performance in terms of accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of delta and theta activation in the DLPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase in neural connectivity for delta and theta bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ventriculoperitoneal shunt infection/dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: mean hearing loss at 500 Hz
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced hearing loss in ACEMg-treated patients compared to placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall of identifying entities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of specific side effects on clinical trial participation
Endpoint domain: Adverse events/effects
Primary endpoint: soft tissue esthetic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone level modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cutaneous wetness of hands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: cutaneous wetness of feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: tactile habituation abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stress intensity during tactile exploration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADR-HA incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of primary end point reporting
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Functional status improvement (BASFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life improvement (HAQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pelvic Floor Distress Inventory (PFDI-20) symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pelvic organ prolapse (POPDI-6) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Colorectal–Anal Distress Inventory (CRADI-8) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Return to work within 35 days after surgery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: smaller bruise area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: median nadir lymphocyte reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Decrease in wrinkle depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in skin elasticity and firmness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time taken for first rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total nalbuphine consumption during the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALSFRS-R score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax (time to maximum concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dose-proportionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of anxiety in patients with Sjogren's syndrome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correlation between fibromyalgia and higher RAPID3 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between higher BMI and greater RAPID3 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCAL gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of vegetable intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of respiratory adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: severity of respiratory adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: meat purchased
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: GMT ratios post-vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: favorable attitude towards diabetes mellitus
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for refill reminder type
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: absolute mobility of the superficial lamina
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flexibility (PSLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating sphingolipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction with results of TJR
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive immune response (cumulative seroconverted SNA and IgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of serum IgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: defervescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospitalization expenses
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Median time to pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically meaningful asthma control improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical ventilation requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased total mean pause duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased intubation pause duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved verbalization before pauses
Endpoint domain: Life impact
Endpoint subdomain: Communication
Primary endpoint: waking due to night sweats
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rates by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POP-Q measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in propofol requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in sufentanil requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Shorter recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in risk of hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: reduction in eating occasions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in visceral fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 12-year disease-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: 12-year overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in %OW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased systolic blood pressure level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: patient expectations of postoperative physical findings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of reports about controlled trials
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: consumption of postoperative analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Severity of stroke (NIHSS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total particle counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Health score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: symmetry of voluntary movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: zygomatic muscle movement symmetry ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of chalazion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVIC repeatability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum detectable change of 13.2 kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between MVIC and 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of confirmed or suspected infection
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: completion rates of ADs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver ablation efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myocardial infarction, stroke, or all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Development of invasive lung cancer
Endpoint domain: Mortality/survival
Primary endpoint: Clearance of bronchial dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: median planning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median percent difference (MPD) below clinical dose limits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average weight increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: nausea/vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of PD‐1 and PD‐L1 expression evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water swallow test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: masticatory ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Daily AF episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first antibiotic modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to antibiotic escalation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to organism ID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of gingival bleeding sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean LSGI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superficial cell percentages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decision certainty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feeling prepared for a decision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to End Stage Kidney Disease (ESKD)
Endpoint domain: Mortality/survival
Primary endpoint: Time to composite end point
Endpoint domain: Mortality/survival
Primary endpoint: No bottle use at bedtime
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Screen time (<1 h/day)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: DAPSA low disease activity (LDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAPSA remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASDAS LDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BHB concentration area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to BHB concentration of 0.5 mmol·L‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin/glucagon ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of recovery (QoR)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total time to exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to taste recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased HbA1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increased fasting blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression or recurrence of symptoms ≥1 h after initial allergic reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anaphylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Symptomatic postural fall in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Height-for-age z-scores (HAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates at 1, 2, and 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polypharmacy (≥5 medications)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potential major DDI
Endpoint domain: Adverse events/effects
Primary endpoint: Potential major DCI
Endpoint domain: Adverse events/effects